French self-testing market rises 15% in 2001
This article was originally published in Clinica
The French market for self-tests grew 15% in 2001, driven mainly by the demand for tests for diabetes, diabetic monitoring tests and pregnancy tests. This represents a significant increase, given that the market was already up 11.7% in 2000 over the previous year.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.